BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38160484)

  • 1. Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan.
    Chen BJ; Hsieh TH; Yuan CT; Wang RC; Yang CF; Chuang WY; Su YZ; Ho CH; Lin CH; Chuang SS
    Pathol Res Pract; 2024 Jan; 253():155059. PubMed ID: 38160484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
    Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS
    Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
    Meer S; Perner Y; McAlpine ED; Willem P
    Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
    Ramis-Zaldivar JE; Gonzalez-Farre B; Nicolae A; Pack S; Clot G; Nadeu F; Mottok A; Horn H; Song JY; Fu K; Wright G; Gascoyne RD; Chan WC; Scott DW; Feldman AL; Valera A; Enjuanes A; Braziel RM; Smeland EB; Staudt LM; Rosenwald A; Rimsza LM; Ott G; Jaffe ES; Salaverria I; Campo E
    Haematologica; 2021 Oct; 106(10):2682-2693. PubMed ID: 33951889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
    Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
    Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.
    Witte HM; Künstner A; Hertel N; Bernd HW; Bernard V; Stölting S; Merz H; von Bubnoff N; Busch H; Feller AC; Gebauer N
    Blood Adv; 2022 Jan; 6(2):637-651. PubMed ID: 34714908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas.
    Leeman-Neill RJ; Soderquist CR; Montanari F; Raciti P; Park D; Radeski D; Mansukhani MM; Murty VV; Hsiao S; Alobeid B; Bhagat G
    Haematologica; 2022 Jan; 107(1):201-210. PubMed ID: 33297669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
    Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
    Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association.
    Chen BJ; Wang RC; Ho CH; Yuan CT; Huang WT; Yang SF; Hsieh PP; Yung YC; Lin SY; Hsu CF; Su YZ; Kuo CC; Chuang SS
    Histopathology; 2018 May; 72(6):930-944. PubMed ID: 29206290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
    Colomo L; Loong F; Rives S; Pittaluga S; Martínez A; López-Guillermo A; Ojanguren J; Romagosa V; Jaffe ES; Campo E
    Am J Surg Pathol; 2004 Jun; 28(6):736-47. PubMed ID: 15166665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.
    Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez de Villambrosia S; Loghavi S; Gomez Mediavilla A; Tonda R; Beltran S; Gut M; Pereña Gonzalez A; d'Ámore E; Visco C; Khoury JD; Montes-Moreno S
    Haematologica; 2021 Apr; 106(4):1120-1128. PubMed ID: 32273478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC status in HIV-associated plasmablastic lymphoma: dual-colour CISH, FISH and immunohistochemistry.
    Pather S; Mashele T; Willem P; Patel M; Perner Y; Motaung M; Nagiah N; Waja F; Philip V; Lakha A; Hale MJ
    Histopathology; 2021 Jul; 79(1):86-95. PubMed ID: 33450085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasmablastic lymphoma: a clinicopathologic analysis of 11 cases with review of literature].
    Li F; Ding W; Zuo Z; Geng N; Yang H; Liu X; Wang J; Yao W; Liu W
    Zhonghua Bing Li Xue Za Zhi; 2016 Jan; 45(1):37-42. PubMed ID: 26791552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmablastic lymphoma: from genetics to treatment.
    Frontzek F; Hailfinger S; Lenz G
    Leuk Lymphoma; 2023 Apr; 64(4):799-807. PubMed ID: 36577021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
    Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
    J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmablastic lymphomas with light chain restriction - plasmablastic extramedullary plasmacytomas?
    Boy SC; van Heerden MB; Raubenheimer EJ; van Heerden WF
    J Oral Pathol Med; 2010 May; 39(5):435-9. PubMed ID: 20537055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ALK-positive large B-cell lymphoma with EBV infection or cyclin D1 expression: a clinicopathological analysis of 3 cases].
    Wu WN; Xiang CX; Ma DS; Liu GZ; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):506-511. PubMed ID: 35673721
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.
    Wang D; Zheng Y; Zeng D; Yang Y; Zhang X; Feng Y; Lu H
    Int J STD AIDS; 2017 Mar; 28(4):380-388. PubMed ID: 27164966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.
    Choudhuri J; Pan Z; Yuan J; Chen M; Wu X; Zheng G; Zhao C; Yuan Y; Agarwal B; Liu J; Ma MY; Wang Y; Shi Y
    Arch Pathol Lab Med; 2023 Jun; 147(6):643-654. PubMed ID: 36161544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway.
    Liu Z; Filip I; Gomez K; Engelbrecht D; Meer S; Lalloo PN; Patel P; Perner Y; Zhao J; Wang J; Pasqualucci L; Rabadan R; Willem P
    Blood Cancer Discov; 2020 Jul; 1(1):112-125. PubMed ID: 33225311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.